ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 546

$542K Total Retail Price of All Prescriptions

Rank: 46 out of 546

367 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 367 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,596 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 299 268 1 1
SIMVASTATIN 237 210 2 2
ATORVASTATIN CALCIUM 224 180 3 11
LEVOTHYROXINE SODIUM 201 122 4 3
PANTOPRAZOLE SODIUM 188 145 5 18
METOPROLOL TARTRATE 186 176 6 6
OMEPRAZOLE 177 128 7 4
FUROSEMIDE 172 160 8 5
METFORMIN HCL 166 125 9 10
ATENOLOL 133 115 10 12
AMLODIPINE BESYLATE 129 127 11 9
MELOXICAM 98 61 12 58
HYDROCHLOROTHIAZIDE 93 84 13 7
METOPROLOL SUCCINATE 88 87 14 17
CITALOPRAM HBR 85 72 15 21
FELODIPINE ER 83 72 16 213
PAROXETINE HCL 79 70 17 43
HYDROCODONE-ACETAMINOPHEN 79 52 S3 17 8
WARFARIN SODIUM 78 54 19 13
GABAPENTIN 75 56 20 16
OXYCONTIN 75 24 S2 20 75
ZOLPIDEM TARTRATE 74 60 22 26
KLOR-CON M20 74 74 22 57
PROAIR HFA 73 55 24 27
OXYCODONE HCL 71 0 S2 25 15
OXYCODONE-ACETAMINOPHEN 70 44 S2 26 54
NEXIUM 69 34 27 52
VENTOLIN HFA 64 50 28 63
CYMBALTA 62 50 29 37
LOVASTATIN 62 55 29 22
FLUTICASONE PROPIONATE 61 41 31 42
ADVAIR DISKUS 61 40 31 20
GEMFIBROZIL 55 41 33 100
CYCLOBENZAPRINE HCL 55 26 R 33 34
SERTRALINE HCL 54 52 35 14
ISOSORBIDE MONONITRATE ER 53 45 36 32
DIVALPROEX SODIUM 53 36 36 78
PREDNISONE 53 34 36 29
DONEPEZIL HCL 53 53 36 31
GLYBURIDE 52 50 R 40 45
LIPITOR 50 40 41 80
AZITHROMYCIN 50 34 41 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.